These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8870737)
1. Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs. Kravis LD; Vail DM; Kisseberth WC; Ogilvie GK; Volk LM J Am Vet Med Assoc; 1996 Oct; 209(8):1418-20. PubMed ID: 8870737 [TBL] [Abstract][Full Text] [Related]
2. Use of the argyrophilic nucleolar region method for cytologic and histologic examination of the lymph nodes in dogs. Vajdovich P; Psáder R; Tóth ZA; Perge E Vet Pathol; 2004 Jul; 41(4):338-45. PubMed ID: 15232133 [TBL] [Abstract][Full Text] [Related]
3. Prognosis of canine mast cell tumors: a comparison of three methods. Simoes JP; Schoning P; Butine M Vet Pathol; 1994 Nov; 31(6):637-47. PubMed ID: 7863578 [TBL] [Abstract][Full Text] [Related]
4. Adapted technique for demonstrating argyrophilic nucleolar organizer regions in the cytologic samples of canine mast cell tumors. Mann TR; Engelmann AM; Mello CBE; de Andrade CM Vet Clin Pathol; 2022 Dec; 51(4):495-497. PubMed ID: 35470473 [TBL] [Abstract][Full Text] [Related]
5. Comparison of argyrophilic nucleolar organizer regions by counting and image analysis in canine mammary tumors. Destexhe E; Vanmanshoven P; Coignoul F Am J Vet Res; 1995 Feb; 56(2):185-7. PubMed ID: 7717583 [TBL] [Abstract][Full Text] [Related]
6. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [TBL] [Abstract][Full Text] [Related]
7. An improved system for quantifying AgNOR and PCNA in canine tumors. Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753 [TBL] [Abstract][Full Text] [Related]
8. What is your diagnosis? Mast cell sarcoma. Dunn K J Small Anim Pract; 1997 Mar; 38(3):93, 108. PubMed ID: 9097238 [No Abstract] [Full Text] [Related]
9. Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours. Bostock DE; Crocker J; Harris K; Smith P Br J Cancer; 1989 Jun; 59(6):915-8. PubMed ID: 2500145 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Ginn PE; Fox LE; Brower JC; Gaskin A; Kurzman ID; Kubilis PS Vet Pathol; 2000 Jan; 37(1):33-9. PubMed ID: 10643978 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. Abadie JJ; Amardeilh MA; Delverdier ME J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425 [TBL] [Abstract][Full Text] [Related]
12. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. Scase TJ; Edwards D; Miller J; Henley W; Smith K; Blunden A; Murphy S J Vet Intern Med; 2006; 20(1):151-8. PubMed ID: 16496935 [TBL] [Abstract][Full Text] [Related]
13. Argyrophilic nucleolar organizer regions staining for cytology smears in dogs and cats. Furusawa Y; Takahashi M; Shima-Sawa M; Yamato O; Yabuki A J Vet Med Sci; 2020 Sep; 82(9):1267-1270. PubMed ID: 32641597 [TBL] [Abstract][Full Text] [Related]
14. Argyrophilic nucleolar organizer region in endoscopically obtained biopsy tissue: a useful predictor of nodal metastasis and prognosis in carcinoma of the stomach. Kakeji Y; Maehara Y; Orita H; Emi Y; Ichiyoshi Y; Korenaga D; Sugimachi K J Am Coll Surg; 1996 Jun; 182(6):482-7. PubMed ID: 8646347 [TBL] [Abstract][Full Text] [Related]
15. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002). Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784 [TBL] [Abstract][Full Text] [Related]
17. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome. Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386 [TBL] [Abstract][Full Text] [Related]
18. Nucleolar organizer region count and subjective AgNOR pattern assessment (SAPA) score in skin tumors. Khanna AK; Giri AK; Khanna A; Kumar M J Surg Oncol; 2001 Dec; 78(4):273-8. PubMed ID: 11745824 [TBL] [Abstract][Full Text] [Related]
19. Application of rapid CD3 immunophenotype analysis and argyrophilic nucleolar organizer region (AgNOR) frequency to fine needle aspirate specimens from dogs with lymphoma. Vail DM; Kravis LD; Kisseberth WC; Ogilvie GK; Volk LM Vet Clin Pathol; 1997; 26(2):66-69. PubMed ID: 12658597 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]